It's an all-cash deal; company is eyeing multiple acquisitions in the near future to further boost its position in the sports media landscape
Shares of HDFC AMC last closed at Rs 1,677. The stock is down 13 per cent in the past six months. GQG was recently in news for its $1.9 billion share purchase of four Adani group stocks
TikTok's owners may retain some form of ownership but through a passive structure
Shriram Housing Finance Ltd., which offers home loans, largely in the affordable housing segment, has received interest from several private equity players, including BPEA EQT, formerly Baring PE Asia
Oliva Skin & Hair Clinic, which is a medico-aesthetic dermatology services player, has said it has sold majority stake to Kedaara Capital for a consideration of USD 65 million (around Rs 530 crore). With its third investment in the single speciality healthcare segment, Kedaara aims to fuel Oliva's growth towards becoming a leading medico-aesthetic dermatology chain, a statement said. The transaction also provides an exit to InvAscent, which invested in the company in 2014, it said, without disclosing the details such how much was invested and for what stake. Nor the company disclosed what is the stake that Kedaara has picked up. Founded by Prashant Soma in 2009, Oliva has been supported by multiple rounds of funding from InvAscent-advised India Life Sciences Fund II. Oliva grew from a four-centre Hyderabad-based operation to a network of 23 centres across Bengaluru, Chennai, Pune, Kolkata, Kochi and Vizag now and offers a range of skin and hair treatments and products. Kedaara is
Business Standard brings you the latest headlines at this hour
Temasek will buy controlling stake in Manipal at $4-billion valuation
Chola says it 'has not expressed any interest either in the past or present in acquiring' Aptus Value
The Middle Eastern sovereign wealth fund is finalizing an agreement to buy a mix of existing Lenskart shares and new equity, the people said
The move is part of the acquirer's strategy to expand into newer related-product segments and leverage its global distribution reach
Jain's career as a portfolio manager started in 1994 when he joined Vontobel Asset Management
The promoters plan to use the proceeds to retire debt and for other corporate purposes
"The investment has made GQG a key investor in the development and growth of critical Indian infrastructure," it said
According to data available at the Bombay Stock Exchange (BSE), SoftBank sold shares worth Rs 954 crore in Delhivery in a bulk deal at Rs 340 apiece
Delhivery had come out with a Rs 5,235 crore IPO in May 2022
The Indian conglomerate had been in advanced discussions to take control of Bisleri and the parties were working on finalizing the structure of a transaction, the people said
Singaporean sovereign fund Temasek Holdings is in advanced talks to buy a minority stake in Cloudnine Hospitals, valuing the Indian hospital chain at Rs 30 billion ($362.7 million)
At the end of December, Alibaba had 6.26 per cent stake in the firm and it had sold around 3 per cent of it in January
The government is likely to sell a part of its residual stake in Hindustan Zinc Ltd by next month to help it achieve the revised sell-off target of Rs 50,000 crore for the current fiscal, DIPAM Secretary Tuhin Kanta Pandey said on Thursday. For the coming fiscal, the government has lined up strategic stake sales in companies like HLL Lifecare, PDIL, Shipping Corporation and BEML to meet the similar disinvestment target set in the 2023-24 Budget. The government currently holds a 29.54 per cent stake in Hindustan Zinc or HZL. In 2002, it sold 26 per cent of HZL to the mining billionaire Anil Agarwal-led group. Vedanta group later bought 20 per cent from the market and another 18.92 per cent from the government in November 2003, raising its ownership to 64.92 per cent in HZL, which is the world's second-largest integrated Zinc producer and sixth-largest silver producer globally. The government on Wednesday lowered the disinvestment target for the current fiscal (2022-23) to Rs 50,000
Bengaluru-based Biocon had in September 2022 sold a 5.4% stake in the open market, as per an exchange filing